Description

Patients with recurrent or metastatic renal cell carcinoma can be separated into 5 risk groups based on clinical status, with the assigned status correlating with prognosis.


 

Patients inclusion: recurrent and/or metastatic renal cell carcinoma

 

Patient Exclusion:

• initial ECOG performance status 4

• major surgery within 3 weeks

• inadequate bone marrow or liver function

• exploratory surgery or biopsy within 2 weeks (reason for exclusion not stated)

• any chemotherapy or radiotherapy within 1 month unless there was disease progression and all treatment related complications were abated

 

Risk factors:

(1) initial ECOG performance status

(2) time from initial diagnosis

(3) weight loss in previous 6 months

(4) history of previous cytotoxic chemotherapy

Risk Factors

Values

Points

initial ECOG performance status

0

0

 

1

1

 

2

2

 

3

3

 

4

(excluded)

time from initial diagnosis

> 1 year

0

 

<= 1 year

1

number of metastatic sites

0 or 1 metastatic sites

0

 

> 1 metastatic sites

1

weight loss in previous 6 months

absent

0

 

present

1

prior cytotoxic chemotherapy

no

0

 

yes

1

 

where:

• 0 metastatic sites indicates locally recurrent disease only

 

Metastatic Site

Count As

lung parenchyma and/or pleura

1

liver

1

brain

1

all other sites combined

1

 

sum of risk factors =

= (points for ECOG status) + (points for time from initial diagnosis) + (point for number of metastatic sites) + (point for weight loss) + (point for cytotoxic chemotherapy)

 

subscore =

= (point for number of metastatic sites) + (point for weight loss) + (point for cytotoxic chemotherapy)

 

effective number of risk factors =

= (sum of risk factors) - (1 if subscore = 3, else 0)

 

Interpretation:

• minimum effective number of risk factors 0

• maximum effective number of risk factors 6

 

Effective Number of Risk Factors

Risk Group

Survival Rate at 1 Year

Median Survival in Months

0 or 1

1

52%

12.8

2

2

31%

7.7

3

3

18%

5.3

4

4

9%

3.4

5 or 6

5

1%

2.1

 


To read more or access our algorithms and calculators, please log in or register.